B vitamins reduce schizophrenia symptoms, study finds

February 16, 2017, University of Manchester
Functional magnetic resonance imaging (fMRI) and other brain imaging technologies allow for the study of differences in brain activity in people diagnosed with schizophrenia. The image shows two levels of the brain, with areas that were more active in healthy controls than in schizophrenia patients shown in orange, during an fMRI study of working memory. Credit: Kim J, Matthews NL, Park S./PLoS One.

A review of worldwide studies has found that add-on treatment with high-dose b-vitamins - including B6, B8 and B12 - can significantly reduce symptoms of schizophrenia more than standard treatments alone.

The research - on the effect of vitamin and on of schizophrenia - is funded by The Medical Research Council and University of Manchester, and is published in Psychological Medicine, one of the world's leading psychology journals

Lead author Joseph Firth, based at the University's Division of Psychology and Mental Health, said: "Looking at all of the data from of vitamin and mineral supplements for schizophrenia to date, we can see that B vitamins effectively improve outcomes for some .

"This could be an important advance, given that new treatments for this condition are so desperately needed."

Schizophrenia affects around 1% of the population and is among the most disabling and costly long term conditions worldwide.

Currently, treatment is based around the administration of antipsychotic drugs.

Although patients typically experience remission of symptoms such as hallucinations and delusions within the first few months of treatment, long-term outcomes are poor; 80% of patients relapse within five years.

The researchers reviewed all reporting effects of vitamin or mineral supplements on psychiatric symptoms in people with schizophrenia.

In what is the first meta-analysis carried out on this topic, they identified 18 clinical trials with a combined total of 832 patients receiving antipsychotic treatment for schizophrenia.

B-vitamin interventions which used higher dosages or combined several vitamins were consistently effective for reducing , whereas those which used lower doses were ineffective.

Also, the available evidence also suggests that B-vitamin supplements may be most beneficial when implemented early on, as b-vitamins were most likely to reduce symptoms when used in studies of patients with shorter illness durations.

Firth added: "High-dose B-vitamins may be useful for reducing residual symptoms in people with schizophrenia, although there were significant differences among the findings of the studies we looked at."

"There is also some indication that these overall effects may be driven by larger benefits among subgroups of patients who have relevant genetic or dietary nutritional deficiencies."

Co-author Jerome Sarris, Professor of Integrative Mental Health at Western Sydney University, added: "This builds on existing evidence of other food-derived supplements, such as certain amino-acids, been beneficial for people with .

"These new findings also fit with our latest research examining how multi-nutrient treatments can reduce depression and other disorders."

The research team say more studies are now needed to discover how nutrients act on the brain to improve , and to measure effects of nutrient-based treatments on other outcomes such as brain functioning and metabolic health.

Explore further: Exercise can tackle symptoms of schizophrenia

Related Stories

Exercise can tackle symptoms of schizophrenia

August 12, 2016
Aerobic exercise can significantly help people coping with the long-term mental health condition schizophrenia, according to a new study from University of Manchester researchers.

Vitamin D deficiency raises risk of schizophrenia diagnosis

July 22, 2014
Vitamin D-deficient individuals are twice as likely to be diagnosed with schizophrenia as people who have sufficient levels of the vitamin, according to a new study published in the Endocrine Society's Journal of Clinical ...

High rates of smoking among schizophrenia patients attributed to nicotine's ameliorative effect

December 6, 2016
The smoking rate among individuals with schizophrenia has been shown to be as high as 90 percent, compared to between 20 and 23 percent of the general population, or 50 percent among individuals with other mental disorders.

A comparison between quetiapine and aripiprazole for treatment of schizophrenia

July 13, 2016
Schizophrenia is a common cause of incapacity and is ranked as the third-most-disabling illness subsequent to dementia and quadriplegia. Nearly, 75% of persons with schizophrenia have continuing problems with recurrent psychotic ...

Multivitamin and mineral supplements for mums-to-be are needless expense

July 11, 2016
Multivitamin and mineral supplements, often promoted to pregnant women as a means of giving their child the best possible start in life, are unlikely to be needed by most mums- to-be and are an unnecessary expense, concludes ...

Clozapine benefits those with tx-resistant schizophrenia

December 1, 2015
(HealthDay)—Clozapine reduces symptoms in patients with schizophrenia who don't benefit from other antipsychotic medications, according to research published online Nov. 6 in The American Journal of Psychiatry.

Recommended for you

Cannabis—it matters how young you start

May 18, 2018
Canadian researchers find that boys who start smoking pot before 15 are much more likely to have a drug problem at 28 than those who start at 15 or after.

Long legs turn women's heads, arm length immaterial: study

May 16, 2018
Labouring over the age-old question "What do women look for in men?", scientists added an item to the list Wednesday: legs slightly longer than average, with a good shin-to-thigh ratio.

Elevated homocysteine identified as metabolic risk factor for neurodegenerative diseases

May 16, 2018
The amino acid homocysteine occurs naturally in the human body, generated as a byproduct of methionine metabolism. Genetic diseases or an imbalanced diet, with too much red meat or deficiencies in B vitamins and folic acid, ...

Researchers find clues to treating psychoses in mental health patients

May 16, 2018
Psychotic disorders often are severe and involve extreme symptoms such as delusions or hallucinations in which people lose their sense of reality. Researchers at the University of Missouri recently found evidence that boosting ...

Most deprived are nearly twice as likely to develop dementia

May 16, 2018
Older adults in England with fewer financial resources are more likely to develop dementia, according to new UCL research.

People make different moral choices in imagined versus real-life situations

May 16, 2018
Researchers often use hypothetical scenarios to understand how people grapple with moral quandaries, but experimental results suggest that these scenarios may not always reflect real-life behavior. The findings, published ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.